Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

JPMorgan Chase & Co. (JPM)’s Earnings Tell the Story They Want You to Hear

Page 1 of 2

JPMorgan Chase & Co. (NYSE:JPM recently reported a massive increase in quarterly income in its Q4 results that seems to defy any concerns related to the volatility of the global economy. The better than expected results have come thanks to a mix of lower tax rates, an improved performance from the corporate and investment banking units of Bank of America Corp (NYSE:BAC) and a large reduction in loan loss reserves – a common theme this earnings season for banks extending the narrative that all is well.

JPMorgan Chase & Co (NYSE:JPM)Net revenue for JP Morgan increased from $21.5 billion last year to $24 billion in 2012. JP Morgan earned $8.2 billion in corporate and investment banking, $182 million more than analysts’ estimates. Investment banking fees rose 54% to $1.7 billion and account for the positive performance by this division while equity and debt underwriting posted a 13% and 23% increase respectively. The bank’s net income increased by 35% from last year’s $3.7 billion to reach $5.7 billion. This growth was strongly supported by JP Morgan’s banking and asset management segment. EPS rose to $1.39, which is 23 cents more than analysts’ estimates and 49 cents more from the earnings of the year-ago-quarter.

Meanwhile, CEO and Chairman Jamie Dimon is being penalized by the board and will receive “only” $11.5 million as opposed to the $23 million he received as compensation in 2011 from the “London Whale” loss, which cost the company $6 billion. The scandal has been particularly embarrassing for JP Morgan and its chief Dimon, who has been openly opposing any moves towards tougher regulations on banks. The bank’s CIO and Treasury unit earned net revenue of negative $110 million as opposed to a positive $845 million last year, while its net loss was $157 million as opposed to $845 million in the previous year. However, the worst isn’t over yet as CIO and Treasury’s net loss is expected to widen to about $300 million in the current quarter.

In the end, the major U.S. banks operate in a near risk-free environment thanks to the Federal Reserve’s policies designed to keep their leveraged bets liquid when the markets were illiquid.  Now, with the long end of the yield curve rising liquidity in the shadow banking system will be even harder to maintain, requiring even more intervention on the FOMC’s part.

Changes that occur within the U.S. banking sector continue to leave management intact while gutting staff.  JPM’s shutdown of part of its settlement over fraudulent foreclosures led to 529 job eliminations, and, according to the Wall Street Journal, the bank fired another 310 employees recently. The bank’s settlement amount is almost $2 billion out of which $753 million will be paid in cash.

It is difficult to achieve sustainable growth in traditional banking at zero-bound interest rates. The latest rounds of QE are designed to get credit flowing, versus simply propping up failing credit pyramids in the shadow banking system, so we’ll see JP Morgan and others expanding their loan books.  Mortgage originations increased 33% from last year to $52 billion. Commercial loans also witnessed a 14% rise in the quarter to reach record levels of $128 billion. According to the bank, it has offered 1.4 million mortgage modifications since 2009, yet the value of its non-performing loan portfolio continues to rise.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!